Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats

Author(s): Ting Xu, Kuikui Zhang, Fuqiang Kan, Fengqin Li, Bo Yu, Wenjuan Du*, Honggang Nie*.

Journal Name: Current Molecular Medicine

Volume 19 , Issue 2 , 2019

  Journal Home
Translate in Chinese
Submit Manuscript
Submit Proposal

Abstract:

Background: Despite intensive investigation, effective therapeutic procedures for myocardial I/R injury are still in demand.

Objective: To explore the effect of adeno-associated virus 9 (AAV9)-mediated small interfering RNA targeting TLR4 in the treatment of myocardial ischemia and reperfusion (I/R) injury and its influence on the NF-κB and MAPK signaling pathways.

Methods: Rats were divided into 3 groups, namely, the sham, AAV9-siRNA control, and AAV9-TLR4 siRNA groups. siRNA solution or normal saline was injected through the tail vain. The rat myocardial I/R injury model was then established. HE staining and TUNEL staining were applied to compare the pathological changes in cardiomyocytes in the three groups. Immunohistochemical staining and western blotting were utilized to detect TLR4 expression under siRNA interference. Serum inflammatory factor (IL-1β, TNF-α) expression was determined by an ELISA commercial kit. Key proteins in the MAPK (p38, JNK 1/2) and NF-κB (p65) signaling pathways were determined to identify the TLR4 siRNA functional mechanism.

Results: Fluorescence microscopic images of the myocardium indicated that AAV9- mediated siRNA was efficiently transfected into the myocardium, and the infarcted size after I/R injury was decreased by AAV9-TLR4 siRNA when compared with negative control rats (P<0.05). TLR4 protein expression was significantly decreased by siRNA interference (P<0.001). Apoptosis-related factor BCL-2 expression was increased in the TLR4 gene silencing group, whereas Bax expression was decreased. The Bax/BCL-2 ratio was also decreased, demonstrating a protective effect for cardiomyocytes. Inflammatory factors were lower in the TLR4 gene silencing group than in the siRNA control group (P<0.001). The MAPK and NF-κB signaling pathways were activated in myocardial I/R injury; however, the primary proteins in these two signaling pathways were downregulated upon interference of TLR4 siRNA, with significant differences (P<0.05).

Conclusion: AAV9-TLR4 siRNA has a positive effect on myocardial I/R injury by inhibiting the MAPK and NF-κB signaling pathways and can be used as a potential therapeutic method for myocardial I/R injury.

Keywords: Myocardial I/R injury, AAV9-TLR4 siRNA, MAPK, NF-κB, inflammatory, ischemia.

[1]
Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005; 14(4): 170-5.
[2]
Ma L, Liu H, Xie Z, et al. Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-κB pathway: A mouse cardiomyocyte model. PLoS One 2014; 9(8): e103628.
[3]
Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovas-cular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59(4): 418-58.
[4]
Yang J, Zhang XD, Yang J, et al. The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4. Mol Biol Rep 2011; 38(5): 3037-44.
[5]
Vilahur G, Badimon L. Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor. Front Physiol 2014; 5: 64.
[6]
Zhai Y, Ao L, Cleveland JC, et al. Toll-like receptor 4 mediates the inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium in a mouse model of myocardial ischemia and reperfusion. PLoS One 2015; 10(3): e0121853.
[7]
Yuan L, Dai X, Fu H, et al. Vaspin protects rats against myocardial ischemia/reperfusion injury (MIRI) through the TLR4/NF-κB signaling pathway. Eur J Pharmacol 2018; 835: 132-9.
[8]
Chong AJ, Shimamoto A, Hampton CR, et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004; 128(2): 170-9.
[9]
Cha J, Wang Z, Ao L, et al. Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 2008; 85(5): 1678-85.
[10]
Zhang X, Du Q, Yang Y, et al. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Biomed Pharmacother 2017; 91: 1042-52.
[11]
Wu H, Liu H, Zuo F, Zhang L. Adenoviruses-mediated RNA interference targeting cytosolic phospholipase A2α attenuates focal ischemic brain damage in mice. Mol Med Rep 2018; 17(4): 5601-10.
[12]
Poller W, Lennart S, Henry F, et al. Chronic Cardiac-Targeted RNA Interference for the Treatment of Severe Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy. Circulation 2009; 119(9): 1241-52.
[13]
Gao C, Liu Y, Yu Q, et al. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregu-lating adiponectin. Am J Physiol Heart Circ Physiol 2015; 308(12): H1583-91.
[14]
Xue Q, Pei H, Liu Q, et al. MICU1 protects against myocardial ischemia/reperfusion injury and its control by the importer receptor Tom70. Cell Death Dis 2017; 8(7): e2923.
[15]
Balan I, Warnock KT, Puche A, Gondre-Lewis MC, June H, Aurelian L. The GABAA receptor α2 subunit activates a neuronal TLR4 signal in the ventral tegmental area that regulates alcohol and nicotine abuse. Brain Sci 2018; 8(4): E72.
[16]
Hao YL, Fang HC, Zhao HL, et al. The role of microRNA-1 targeting MAPK3 in myocardial ischemia/reperfusion injury in rats undergoing sevoflurane preconditioning via the PI3K/Akt pathway. Am J Physiol Cell Physiol 2018; 315(3): C380-8.
[17]
Liu Z, Kastis GA, Stevenson GD, et al. Quantitative analysis of acute myocardial infarct in rat hearts with ischemia–reperfusion using a high-resolution stationary SPECT system. J Nucl Med 2002; 43(7): 933-9.
[18]
Wu FX, Bian JJ, Miao XR, et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci 2010; 7(5): 251-9.
[19]
Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99(13): 1685-91.
[20]
Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61(3): 427-36.
[21]
Xia Z, Li H, Irwin MG. Myocardial ischaemia reperfusion injury: The challenge of translating ischaemic and anaesthetic protection from animal models to humans. Br J Anaesth 2016. 117(suppl_2): ii44-62
[22]
Pinto DS, Gibson CM. Reperfusion injury of the heart.UpToDate, Waltham, MA. (Accessed on January 04, 2016)
[23]
Chen H, Zhang RQ, Wei XG, Ren XM, Gao XQ. Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse. Asian Pac J Trop Med 2016; 9(5): 503-7.
[24]
Wu B, Meng K, Ji Q, et al. Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin Exp Immunol 2014; 176(3): 438-51.
[25]
Schuster JM, Nelson PS. Toll receptors: An expanding role in our understanding of human disease. J Leukoc Biol 2000; 67(6): 767-73.
[26]
Xie Z, Koyama T, Suzuki J, et al. Coronary reperfusion following ischemia. Jpn Heart J 2001; 42(6): 759-70.
[27]
Hochhauser E, Kivity S, Offen D, et al. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 2003; 284(6): H2351-9.
[28]
Guo X, Shang J, Deng Y, Yuan X, Zhu D, Liu H. Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling. Int J Mol Med 2015; 36(1): 150-8.
[29]
Yang X, Yang J, Hu J, Li X, Zhang X, Li Z. Apigenin attenuates myocardial ischemia/reperfusion injury via the inactivation of p38 mitogen activated protein kinase. Mol Med Rep 2015; 12(5): 6873-8.
[30]
Vassalli G, Milano G, Moccetti T. Role of mitogen-activated protein kinases in myocardial ischemia-reperfusion injury during heart transplantation. J Transplant 2012; 2012: 928954.
[31]
Kumphune S, Surinkaew S, Chattipakorn SC, Chattipakorn N. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury. Pharm Biol 2015; 53(12): 1831-41.
[32]
Maimaitiaili A, Li J, Aibibula A, Abudureheman M. Inhibition of nuclear factor kappa B pathway protects myocardial ischemia/reperfusion injury in rats under treatment with abnormal savda munziq. Am J Transl Res 2018; 10(1): 77-85.
[33]
Norman DA, Yacoub MH, Barton PJ. Nuclear factor NF-κB in myocardium: Developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro. Cardiovasc Res 1998; 39(2): 434-41.
[34]
Liang Z1,Liu LF, Yao TM, Huo Y, Han YL. Cardioprotective effects of Guanxinshutong (GXST) against myocardial ischemia/reperfusion injury in rats. J Geriatr Cardiol 2012; 9(2): 130-6.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 19
ISSUE: 2
Year: 2019
Page: [127 - 135]
Pages: 9
DOI: 10.2174/1566524019666190311122521
Price: $58

Article Metrics

PDF: 33
HTML: 2
EPUB: 1
PRC: 1